Annual Operating Margin
-15.43%
+60.25%+79.61%
31 December 2023
Summary:
Alnylam Pharmaceuticals annual operating profit margin is currently -15.43%, with the most recent change of +60.25% (+79.61%) on 31 December 2023. During the last 3 years, it has risen by +152.66% (+90.82%). ALNY annual operating margin is now at all-time high.ALNY Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Margin
-15.35%
-22.72%-308.28%
30 September 2024
Summary:
Alnylam Pharmaceuticals quarterly operating profit margin is currently -15.35%, with the most recent change of -22.72% (-308.28%) on 30 September 2024. Over the past year, it has dropped by -43.85% (-153.86%). ALNY quarterly operating margin is now -153.86% below its all-time high of 28.50%, reached on 30 September 2023.ALNY Quarterly Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALNY Operating Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +79.6% | -153.9% |
| 3 y3 years | +90.8% | +84.2% |
| 5 y5 years | +98.6% | +95.0% |
ALNY Operating Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +90.8% | -153.9% | +84.3% |
| 5 y | 5 years | at high | +98.6% | -153.9% | +96.3% |
| alltime | all time | at high | +99.9% | -153.9% | +100.0% |
Alnylam Pharmaceuticals Operating Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -15.35%(-308.3%) |
| June 2024 | - | 7.37%(-183.8%) |
| Mar 2024 | - | -8.79%(-66.8%) |
| Dec 2023 | -15.43%(-79.6%) | -26.47%(-192.9%) |
| Sept 2023 | - | 28.50%(-139.5%) |
| June 2023 | - | -72.10%(+53.7%) |
| Mar 2023 | - | -46.92%(-16.7%) |
| Dec 2022 | -75.68%(-9.8%) | -56.30%(-42.3%) |
| Sept 2022 | - | -97.63%(+14.5%) |
| June 2022 | - | -85.26%(+23.9%) |
| Mar 2022 | - | -68.80%(-8.6%) |
| Dec 2021 | -83.94%(-50.1%) | -75.26%(-22.3%) |
| Sept 2021 | - | -96.83%(+46.1%) |
| June 2021 | - | -66.27%(-36.8%) |
| Mar 2021 | - | -104.89%(-11.7%) |
| Dec 2020 | -168.09%(-60.7%) | -118.75%(-33.6%) |
| Sept 2020 | - | -178.94%(-6.5%) |
| June 2020 | - | -191.28%(-9.5%) |
| Mar 2020 | - | -211.27%(-49.2%) |
| Dec 2019 | -427.50%(-60.7%) | -415.83%(+34.7%) |
| Sept 2019 | - | -308.73%(-41.6%) |
| June 2019 | - | -528.41%(-6.8%) |
| Mar 2019 | - | -567.03%(-45.9%) |
| Dec 2018 | -1087.56%(+95.5%) | -1047.67%(-91.5%) |
| Sept 2018 | - | -12.30 K%(+1812.9%) |
| June 2018 | - | -643.17%(-4.4%) |
| Mar 2018 | - | -673.11%(+73.3%) |
| Dec 2017 | -556.20%(-38.2%) | -388.42%(-47.2%) |
| Sept 2017 | - | -735.84%(-2.7%) |
| June 2017 | - | -756.18%(+34.6%) |
| Mar 2017 | - | -561.77%(-15.1%) |
| Dec 2016 | -900.33%(+25.0%) | -661.36%(-15.4%) |
| Sept 2016 | - | -781.45%(-26.4%) |
| June 2016 | - | -1061.55%(-29.1%) |
| Mar 2016 | - | -1498.00%(+22.3%) |
| Dec 2015 | -720.27%(+97.7%) | -1225.16%(-1.1%) |
| Sept 2015 | - | -1238.61%(+47.5%) |
| June 2015 | - | -839.88%(+198.1%) |
| Mar 2015 | - | -281.72%(+48.0%) |
| Dec 2014 | -364.34% | -190.32%(-53.8%) |
| Sept 2014 | - | -411.95%(-38.5%) |
| June 2014 | - | -670.25%(+24.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | -536.65%(+96.7%) |
| Dec 2013 | -197.05%(+106.8%) | -272.81%(-23.9%) |
| Sept 2013 | - | -358.51%(+46.1%) |
| June 2013 | - | -245.33%(+366.5%) |
| Mar 2013 | - | -52.59%(-80.9%) |
| Dec 2012 | -95.27%(+43.8%) | -274.90%(+153.9%) |
| Sept 2012 | - | -108.28%(+87.4%) |
| June 2012 | - | -57.78%(+19.0%) |
| Mar 2012 | - | -48.57%(-26.9%) |
| Dec 2011 | -66.24%(+51.5%) | -66.42%(+11.0%) |
| Sept 2011 | - | -59.82%(-6.0%) |
| June 2011 | - | -63.64%(-15.2%) |
| Mar 2011 | - | -75.02%(+31.6%) |
| Dec 2010 | -43.72%(-8.7%) | -57.00%(+80.7%) |
| Sept 2010 | - | -31.55%(-27.8%) |
| June 2010 | - | -43.68%(-5.1%) |
| Mar 2010 | - | -46.03%(+51.9%) |
| Dec 2009 | -47.86%(+65.3%) | -30.31%(-23.8%) |
| Sept 2009 | - | -39.80%(-56.3%) |
| June 2009 | - | -91.10%(+186.0%) |
| Mar 2009 | - | -31.85%(-0.5%) |
| Dec 2008 | -28.95%(-84.2%) | -32.02%(+154.7%) |
| Sept 2008 | - | -12.57%(-76.7%) |
| June 2008 | - | -53.84%(+202.0%) |
| Mar 2008 | - | -17.83%(+12.4%) |
| Dec 2007 | -183.07%(+24.8%) | -15.86%(-95.0%) |
| Sept 2007 | - | -314.67%(+92.2%) |
| June 2007 | - | -163.73%(-50.8%) |
| Mar 2007 | - | -332.47%(+132.3%) |
| Dec 2006 | -146.68%(-80.7%) | -143.12%(+36.6%) |
| Sept 2006 | - | -104.79%(-43.2%) |
| June 2006 | - | -184.50%(+7.7%) |
| Mar 2006 | - | -171.37%(-82.2%) |
| Dec 2005 | -760.53%(+0.8%) | -961.15%(+27.3%) |
| Sept 2005 | - | -755.13%(-25.3%) |
| June 2005 | - | -1011.19%(+148.7%) |
| Mar 2005 | - | -406.63%(+94.5%) |
| Dec 2004 | -754.18%(-93.5%) | -209.03%(-55.5%) |
| Sept 2004 | - | -470.08%(-91.2%) |
| June 2004 | - | -5324.43%(-46.5%) |
| Mar 2004 | - | -9949.25%(-78.7%) |
| Dec 2003 | -11.62 K% | -46.77 K% |
FAQ
- What is Alnylam Pharmaceuticals annual operating profit margin?
- What is the all time high annual operating margin for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals annual operating margin year-on-year change?
- What is Alnylam Pharmaceuticals quarterly operating profit margin?
- What is the all time high quarterly operating margin for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals quarterly operating margin year-on-year change?
What is Alnylam Pharmaceuticals annual operating profit margin?
The current annual operating margin of ALNY is -15.43%
What is the all time high annual operating margin for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high annual operating profit margin is -15.43%
What is Alnylam Pharmaceuticals annual operating margin year-on-year change?
Over the past year, ALNY annual operating profit margin has changed by +60.25% (+79.61%)
What is Alnylam Pharmaceuticals quarterly operating profit margin?
The current quarterly operating margin of ALNY is -15.35%
What is the all time high quarterly operating margin for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high quarterly operating profit margin is 28.50%
What is Alnylam Pharmaceuticals quarterly operating margin year-on-year change?
Over the past year, ALNY quarterly operating profit margin has changed by -43.85% (-153.86%)